Peptide therapy workflow
Compounded peptides are cash-pay, off-label and watched by state boards. Record the consult: Ena drafts the note that documents necessity and consent, builds titration and repeat labs into the care plan, and makes each follow-up justify the renewal.
- Nov 3Baseline labs in the note. Start 200 mcg nightlyCharted
- Nov 17Step to 300 mcg nightly if toleratedReminder set
- Dec 15Follow-up: response and side effectsBooked
- Jan 19Repeat IGF-1 and fasting glucoseOrder drafted
- Jan 26Renewal review against your stop pointYour call
A peptide prescription without a chart behind it is what gets clinics in trouble. The clinics that win will be the ones whose charts hold up.
Ena listens to the visit and writes the note in your format, with the elements a reviewer looks for: the indication, why an approved alternative is not suitable, the consent conversation, the monitoring plan, and the pharmacy it went to. Not a template pasted in. What was actually said in the room, structured the way scrutiny reads it.
- Indication and necessityDiagnosis, why an FDA-approved alternative is not suitable, rationale for this peptide
- Written informed consentCompounded and off-label status, known and unknown risks, monitoring expectations
- Baseline and monitoring labsIGF-1, fasting glucose, HbA1c, lipids reviewed; repeat at 12 weeks
- Pharmacy sourceNamed 503A pharmacy, licensed in the patient's state
- Titration and stop pointDose response recorded against a defined stop point
A peptide service line is protocol-driven, lab-gated and titrated over months. Every step already has a place in Ena's workflow.
- 01
Prep before you walk in
Intake, history and prior labs summarised before the visit. Cancer history, pregnancy status and current medications surfaced, not buried. - 02
Baseline labs, read your way
IGF-1, fasting glucose, HbA1c, lipids, CBC and CMP read in your order and flagged against your ranges, the way you would read them. - 03
The consult
Record the visit. The note documents the indication, medical necessity and the consent conversation in your format, in about 2 minutes. - 04
The care plan
Titration schedule, reconstitution and injection instructions, side effects to report, repeat labs at set intervals and a defined stop point. Your protocols, your dosing. - 05
Follow-ups that justify the renewal
Each visit compared to the last: response, labs that moved, continued justification for renewal. A renewal is a re-evaluation, not a rubber stamp. - 06
Between visits, nothing slips
Dose adjustments and patient questions between visits become pending actions on the chart, so the paper trail stays complete.
Ena does not decide what you can prescribe. Which peptides a 503A pharmacy can compound changes as FDA rules move, and the clinical decision is always yours. We keep a peptide compounding status page as a reference, and your pharmacy has the final word.
Peptide compounding statusWe walk in already prepped.
Dr. Craig TanioCo-Founder & Physician, MD, Rezilir Health“Our visits are the most documentation-heavy in medicine. Genomics, brain imaging, panels most doctors never order. Ena preps the chart before the patient sits down, drafts the note while we talk, and turns the follow-ups into a shared queue my nurse practitioners and coaches actually work from.”
Read the case studyNo. What a 503A pharmacy can compound changes as FDA rules move, and the prescribing decision is always yours. We maintain a peptide compounding status page that tracks where commonly prescribed peptides stand, but it is reference material, not legal or medical advice. Confirm current status with your compounding pharmacy before writing.
Keep reading
- Labs analysisBaseline and monitoring labs read in your order, flagged against your ranges.
- AI care plansTitration, instructions and repeat labs drafted into a plan in your format.
- Practice IntelligenceEncode your protocols once, so your standard monitoring plan is written your way every time.
- Peptide compounding statusWhere commonly prescribed peptides stand under FDA 503A rules, with sources.
Ena drafts the note, the titration plan and the follow-ups from the consult, and sends them to your EMR when you approve.